Using regional pharmaceutical organisations as multipliers in expanding the scope and impact of antimicrobial resistance initiatives
- In: F4 - Combating Antimicrobial resistance for patient safety on Sunday, 6 September 2009, 14:00-17:00
- At: Istanbul (Turkey) (2009)
- Type: Presentation
- By: JOSHI, Mohan (Management Sciences for Health, SPS Program, Arlington, VA, United States of America)
- Co-author(s): Kirika, Rosalind (Management Sciences for Health, SPS Program, Arlington, VA, United States of America)
Green, Terry (Management Sciences for Health, SPS Program, Arlington, VA, United States of America) - Abstract:
Introduction Antimicrobial resistance (AMR) is rapidly eroding gains made in managing infectious diseases. The 2005 World Health Assembly acknowledged that the WHO Global Strategy for Containment of AMR has not been implemented widely. This gap needs to be urgently bridged. Objective To accelerate regional adaptation and implementation of
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023